Oct 31, 2022 / 12:30PM GMT
Operator
Good morning and welcome to the Renalytix Conference Call to review Fourth Quarter and Full Year Fiscal 2022 Financial Results.
At this time all participants are in a listen-only mode. We will be facilitating a question-and-answer session toward the end of today's call. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Peter DeNardo of CapComm Partners, for a few introductory comments.
Peter DeNardo - CapComm Partners - IR
Thank you [Michelle] and thank you all for participating in today's call. Joining me today from Renalytix are James McCollough, Chief Executive Officer; Tom McLain, President; Michael Donovan, Chief Medical Officer and James Sterling, Chief Financial Officer.
Before we begin I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that relate to expectations or predictions of future events,
Full Year 2022 Renalytix PLC Earnings Call Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers